Politicos have expanded their “Enemies of the States” targets beyond the biotech companies as they are now expanding their attacks to other selected groups i.e., wealthy/successful Americans, successful American High-Tech companies like Google, Facebook, Twitter and every American with any type of wealth, especially American Billionaire’s. Politicos are now simultaneously spearheading Biotech-WAR$™, Tech WARS, and now Class WARS, and openly attacking all businesses, especially those that have widespread social links all for their political advantage. Who will the next “others” group/” Enemies of the States” be?
Price tag for Warren's universal healthcare: $20.5T
Elizabeth Warren shares a 'calculator for billionaires' for her wealth tax plan
Billionaire Leon Cooperman has had enough with regard to the onslaught of ‘politico’ attacks on wealthy Americans and is fighting back. Good for him, and it is good to see him do this. Google and Facebook and Twitter should all learn from this and fight back as should every Biotech company, every Bank, every business in the America.
Meanwhile, and irrespective of all the political clatter, the biotech/medtech sectors continue to succeed and are on track to have another banner 2019 both in product development and financial success. The progress and clinical successes of new meds in late October 2019 and early November 2019 have been extraordinary. Highlighted below are a few recent notable biotech/medtech newsworthy press releases;
Genentech's Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared to Standard of Care Alone
Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
Biogen to Expand Biosimilars Portfolio and Gain Access to Additional Markets Through New Transaction with Samsung Bioepis
Aduro Biotech Announces Presentation of Results from First-in-Human Phase 1 Study of Anti-CD27 Agonist as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 34th Annual Meeting
New Data From the Phase III DAPA-HF Trial Showed FARXIGA Reduced the Worsening of Heart Failure or Cardiovascular Death in HFrEF Patients With and Without Chronic Kidney Disease
FDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions
Roxadustat Significantly Increased Hemoglobin Levels for Chronic Kidney Disease Patients with Anemia in Phase III OLYMPUS and ROCKIES Trials
Bristol-Myers Squibb Underscores Precision-Focused Immunology Leadership with New Data on ORENCIA® (abatacept) in Early RA, ACPA-Positive Patients Presented at 2019 ACR/ARP Annual Meeting¹
Harmony® Test: The first non-invasive prenatal test approved by Health Canada
Phase 3 Trial of NINLAROTM (ixazomib) as First Line Maintenance Therapy Met Primary Endpoint in Multiple Myeloma Patients not treated with Stem Cell Transplantation
Mallinckrodt Announces Data Publication on the Treatment Effectiveness of Acthar® Gel (Repository Corticotropin Injection) for Resolution of Multiple Sclerosis Relapse in a U.S. Health Plan Population
Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes
Alkermes to Present Data From ALKS 4230 Clinical Development Program at the Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting
Takeda's Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure
CALQUENCE® Data To Show Improved Progression-Free Survival In Phase III Front-Line Chronic Lymphocytic Leukemia At ASH 2019 Annual Meeting
Regeneron Provides Updates on Phase 3 Libtayo® (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Alibaba Deepens Health Care Interest With Stake in Private Clinic Operator
Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis
AstraZeneca to Present Pivotal Roxadustat Phase III Data at the American Society of Nephrology Kidney Week 2019
Phase 3 Results from Two Studies of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Triple Combination Treatment for Cystic Fibrosis Concurrently Published in The New England Journal of Medicine and The Lancet
FDA Accepts Genentech's Biologics License Application for Satralizumab for Neuromyelitis Optica Spectrum Disorder
First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump
Fosun Dives Deeper Into Health Sector With International Investment Alliance
RINVOQ™ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis
Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
Caixin New Economy Index Rebounds on Rising Capital, Tech Inputs
Glaxo's TB vaccine shows positive effect in mid-stage study; shares up 1%
Bethel Music - Raise A Hallelujah (Official Lyric Video) VICTORY
•Jan 24, 2019 Bethel Music
Bethel Music - Raise A Hallelujah (LIVE) | VICTORYRespectfully submitted to Seeking Alpha on November 9, 2019. As of 11/9/19 I remain 100% invested in biotech and medtech companies. And I remain long all companies noted below;
(MRK) (BMY) (CELG) (PFE) (LLY) (AMGN) (GILD) (AMRN) (VRTX) (BGNE) (ABBV) (AZN) (NVS) (NVO) (MDT) (JNJ) (ABMD) (VAR) (ABT) (BIIB) (REGN) (ILMN) (OTCQX:RHHBY) (BMRN) (AGN) (SGEN) (ISRG)
The SeekingBiotechAlpha portfolio is here =
seekingbiotechalpha.com | danwatson888's Portfolio on GuruFocus.com
The SeekingBiotechAlpha top stock picks are here =
https://seekingbiotechalpha.com/biotech
investments of seeking biotech alpha as of 11/9/2019
So, Raise A Hallelujah & Sing a Little LOUDER
GLTA Dan Watson